In general, operable FGFR3 gene fusion is found relatively commonly in glioma and bladder cancer (Wu et al. 2013), FGFR3–TACC3 fusion has been reported in 2.5% of NPC (Yuan et al. 2014). This evidence concerns the gene FGFR3 and urinary bladder carcinoma.